Literature DB >> 16990337

More on switching statins: comments from Pfizer.

Kate Lloyd.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16990337      PMCID: PMC1570866          DOI: 10.1136/bmj.333.7569.655

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

2.  Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Authors:  P Jones; S Kafonek; I Laurora; D Hunninghake
Journal:  Am J Cardiol       Date:  1998-03-01       Impact factor: 2.778

3.  A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.

Authors:  Anders G Olsson; Mats Eriksson; Owe Johnson; Thomas Kjellström; Jan Lanke; Mogens Lytken Larsen; Terje Pedersen; Matti J Tikkanen; Olov Wiklund
Journal:  Clin Ther       Date:  2003-01       Impact factor: 3.393

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.